POLYCYSTIC OVARY SYNDROME: ITS ASSOCIATION WITH METABOLIC SYNDROME AND INSULIN RESISTANCE
Keywords:
PCOS, insulin resistance, metabolic syndromeAbstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. It is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Increasing evidence suggests a strong association between PCOS, metabolic syndrome (MetS), and insulin resistance (IR). These interconnected conditions significantly increase the risk of type 2 diabetes mellitus, cardiovascular diseases, and long-term morbidity. This article aims to analyze the relationship between PCOS, metabolic syndrome, and insulin resistance by reviewing current clinical and epidemiological data. The findings highlight the importance of early screening and multidisciplinary management strategies.
References
1. World Health Organization (2022). PCOS and metabolic health report.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised diagnostic criteria.
3. Dunaif A. (2016). Insulin resistance in PCOS. Endocrine Reviews. (PubMed indexed)
4. Moran LJ et al. (2010). Metabolic syndrome in PCOS. Human Reproduction Update.
5. Teede HJ et al. (2018). International PCOS guideline. Fertility and Sterility.
6. Diamanti-Kandarakis E. (2007). Insulin resistance in PCOS. Endocrine.
7. Legro RS et al. (2013). Diagnosis and treatment of PCOS. Journal of Clinical Endocrinology & Metabolism
8. Wild RA et al. (2010). Cardiovascular risk in PCOS. Fertility and Sterility
9. Fauser BCJM et al. (2012). PCOS pathophysiology. Lancet
10. Goodman NF et al. (2015). PCOS management guidelines. Endocrine Practice
